COIN Form 4: Chief Legal Officer Exercises Option and Sells Shares Under 10b5-1
Rhea-AI Filing Summary
Paul Grewal, Chief Legal Officer of Coinbase Global, Inc. (COIN), reported transactions dated 08/25/2025 executed under a Rule 10b5-1 trading plan. On that date he exercised an employee stock option to acquire 10,000 shares of Class A common stock at an exercise price of $26.26. The option is exercisable in part and fully vested by August 31, 2024 per the footnotes and contains an early-exercise provision.
Also on 08/25/2025 the reporting person sold multiple blocks totaling 15,439 shares of Class A common stock in several transactions at weighted-average sale prices reported in footnotes, with sale-price ranges from $306.45 up to $315.04. Following the reported transactions, the filing shows 161,722 shares of Class A common stock beneficially owned (direct).
Positive
- Trades executed pursuant to a Rule 10b5-1 plan, indicating pre-planned and compliant insider sales
- Detailed disclosure of weighted-average sale prices and price ranges in footnotes enhances transparency
- Exercise of employee option at $26.26 demonstrates utilization of long-term compensation
Negative
- Insider sold 15,439 shares on 08/25/2025, representing a meaningful disposition of shares held
- Sales executed at high market prices ($306.45–$315.04) could reduce perceived insider ownership concentration
Insights
TL;DR: Insider exercised option and sold shares under a 10b5-1 plan; disclosure is routine and provides liquidity, not new company information.
The Form 4 shows an option exercise of 10,000 shares at $26.26 and subsequent sales of 15,439 shares executed under a Rule 10b5-1 trading plan adopted August 28, 2024. The sales occurred across multiple price steps with weighted averages reported in footnotes and do not disclose any nonpublic operational developments. From a market-impact perspective, these are insider liquidity actions rather than signaling of corporate events; the filing increases transparency about insider holdings and disposition but contains no earnings or strategic information.
TL;DR: Proper use of a 10b5-1 plan and clear footnoted price ranges indicate compliance-focused insider activity.
The reporting indicates the trades were effected pursuant to a pre-established Rule 10b5-1 plan, which provides an affirmative defense against insider trading claims when properly adopted. The filing includes detailed footnotes disclosing weighted-average prices and price ranges for each block sold, and the signature by an attorney-in-fact is present. These elements reflect governance discipline and timely SEC disclosure, reducing regulatory risk associated with insider trades.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (right to buy) | 10,000 | $0.00 | -- |
| Exercise | Class A Common Stock | 10,000 | $26.26 | $263K |
| Sale | Class A Common Stock | 571 | $306.8771 | $175K |
| Sale | Class A Common Stock | 2,069 | $307.9333 | $637K |
| Sale | Class A Common Stock | 3,139 | $309.2888 | $971K |
| Sale | Class A Common Stock | 2,368 | $310.1332 | $734K |
| Sale | Class A Common Stock | 1,732 | $311.0644 | $539K |
| Sale | Class A Common Stock | 2,157 | $312.1879 | $673K |
| Sale | Class A Common Stock | 1,015 | $312.9879 | $318K |
| Sale | Class A Common Stock | 2,012 | $314.4264 | $633K |
| Sale | Class A Common Stock | 376 | $314.8969 | $118K |
Footnotes (1)
- The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024, during an open trading window. Represents the weighted average sale price. The lowest price at which shares were sold was $306.45 and the highest price at which shares were sold was $307.01. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the ranges set forth in footnotes (2) through (10) to this Form 4. Represents the weighted average sale price. The lowest price at which shares were sold was $307.50 and the highest price at which shares were sold was $308.40. Represents the weighted average sale price. The lowest price at which shares were sold was $308.70 and the highest price at which shares were sold was $309.68. Represents the weighted average sale price. The lowest price at which shares were sold was $309.70 and the highest price at which shares were sold was $310.69. Represents the weighted average sale price. The lowest price at which shares were sold was $310.71 and the highest price at which shares were sold was $311.695. Represents the weighted average sale price. The lowest price at which shares were sold was $311.72 and the highest price at which shares were sold was $312.70. Represents the weighted average sale price. The lowest price at which shares were sold was $312.73 and the highest price at which shares were sold was $313.58. Represents the weighted average sale price. The lowest price at which shares were sold was $313.84 and the highest price at which shares were sold was $314.795. Represents the weighted average sale price. The lowest price at which shares were sold was $314.84 and the highest price at which shares were sold was $315.04. 1/4 of the total shares underlying the option vested on August 31, 2021 and the remaining 3/4th of the shares underlying the option will vest in equal monthly installments thereafter until the option is fully vested on August 31, 2024, subject to the Reporting Person's continued service to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.